Invesco Ltd (IVZ) concluded trading on Thursday at a closing price of $17.90, with 3.05 million shares of worth about $54.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.30% during that period and on December 05, 2024 the price saw a loss of about -1.10%. Currently the company’s common shares owned by public are about 449.44M shares, out of which, 441.87M shares are available for trading.
Stock saw a price change of -0.78% in past 5 days and over the past one month there was a price change of 0.22%. Year-to-date (YTD), IVZ shares are showing a performance of 0.34% which increased to 19.33% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $14.16 but also hit the highest price of $18.94 during that period. The average intraday trading volume for Invesco Ltd shares is 3.58 million. The stock is currently trading 0.16% above its 20-day simple moving average (SMA20), while that difference is up 0.48% for SMA50 and it goes to 9.65% higher than SMA200.
Invesco Ltd (NYSE: IVZ) currently have 449.44M outstanding shares and institutions hold larger chunk of about 87.05% of that.
The stock has a current market capitalization of $8.04B and its 3Y-monthly beta is at 1.42. It has posted earnings per share of -$0.92 in the same period. It has a debt-to-equity ratio of 0.51. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IVZ, volatility over the week remained 1.97% while standing at 2.02% over the month.
Stock’s fiscal year EPS is expected to rise by 10.80% while it is estimated to increase by 12.61% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on September 12, 2024 offering an Underweight rating for the stock and assigned a target price of $16 to it. Coverage by Barclays stated Invesco Ltd (IVZ) stock as an Equal weight in their note to investors on August 27, 2024, suggesting a price target of $18 for the stock. On January 04, 2024, TD Cowen Initiated their recommendations, while on December 14, 2023, Keefe Bruyette Upgrade their ratings for the stock with a price target of $20. Stock get a Market perform rating from BMO Capital Markets on July 10, 2023.
